For research use only. Not for therapeutic Use.
Gaboxadol Hydrochloride (Cat.No:R042364) is a GABAergic agonist used in scientific research. It activates GABA receptors, resulting in inhibitory neurotransmission. Although studied for its potential in treating insomnia and other disorders, clinical development faced challenges. Research on Gaboxadol Hydrochloride continues to explore its neurological effects and potential therapeutic applications.
| Catalog Number | R042364 |
| CAS Number | 85118-33-8 |
| Synonyms | 4,5,6,7-Tetrahydro-isoxazolo[5,4-c]pyridin-3(2H)-one |
| Molecular Formula | C6H9ClN2O2 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble in DMSO > 10 mM |
| Storage | Store at RT |
| IUPAC Name | 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one;hydrochloride |
| InChI | InChI=1S/C6H8N2O2.ClH/c9-6-4-1-2-7-3-5(4)10-8-6;/h7H,1-3H2,(H,8,9);1H |
| InChIKey | ZDZDSZQYRBZPNN-UHFFFAOYSA-N |
| SMILES | C1CNCC2=C1C(=O)NO2.Cl |
